2 months ago
BBIO
AnalystsJoshua SchimmerJoshua Schimmer's Stock Forecasts
AnalystsJoshua Schimmer
Analyst Ranking
Top 7%
#303 out of 4587 analysts
Average Return
+17.36%
Win Rate
51%48 out of 95
Risk vs Reward
Poor
Good
Joshua Schimmer's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Longboard Pharmaceuticals IncLBPH | +300.19% | $5.17 | $20.69 | 2023-10-24 - 2024-05-17 | Strong Buy |
Longboard Pharmaceuticals IncLBPH | +274.82% | $5.52 | $20.69 | 2023-12-20 - 2024-05-17 | Strong Buy |
Longboard Pharmaceuticals IncLBPH | +266.84% | $5.64 | $20.69 | 2023-12-19 - 2024-05-17 | Strong Buy |
Voyager Therapeutics IncVYGR | +183.31% | $8.57 | $24.28 | 2017-08-17 - 2018-03-12 | Buy |
Avidity Biosciences IncRNA | +144.21% | $12.08 | $29.50 | 2023-05-22 - 2024-05-17 | Buy |
Joshua Schimmer Analyst Color
Get additional color on Joshua Schimmer's coverage of popular stocks
4 months ago
LBPH
5 months ago
LBPH
6 months ago
VTYX
7 months ago
LBPH
Joshua Schimmer's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Crinetics Pharmaceuticals IncCRNX | 5 | Strong Buy | $65.00 | +26.46% | Reiterates | 6 days ago |
Mirum Pharmaceuticals IncMIRM | 6 | Strong Buy | $40.00 | +66.18% | Reiterates | 11 days ago |
Janux Therapeutics IncJANX | 2 | Strong Buy | $100.00 | +112.31% | Reiterates | 11 days ago |
Cg Oncology IncCGON | 3 | Strong Buy | $75.00 | +150.17% | Reiterates | 14 days ago |
Longboard Pharmaceuticals IncLBPH | 9 | Strong Buy | $60.00 | +190.00% | Reiterates | 17 days ago |
Xenon Pharmaceuticals IncXENE | 1 | Strong Buy | $65.00 | +63.32% | Reiterates | a month ago |
Cabaletta Bio IncCABA | 4 | Strong Buy | $50.00 | +304.86% | Reiterates | a month ago |
Bridgebio Pharma IncBBIO | 5 | Strong Buy | $70.00 | +132.64% | Maintains | 2 months ago |
Rocket Pharmaceuticals IncRCKT | 3 | Strong Buy | $65.00 | +187.36% | Maintains | 3 months ago |
Rallybio CorpRLYB | 2 | Buy | $15.00 | +747.46% | Maintains | 5 months ago |
Krystal Biotech IncKRYS | 3 | Strong Buy | $180.00 | +9.69% | Maintains | 5 months ago |
Ventyx Biosciences IncVTYX | 2 | Hold | $5.00 | +5.71% | Downgrades | 6 months ago |
4d Molecular Therapeutics IncFDMT | 1 | Strong Buy | $32.00 | +26.28% | Initiates Coverage On | 7 months ago |
Insmed IncINSM | 2 | Buy | $42.00 | +69.56% | Maintains | 8 months ago |
Otis Worldwide CorpOTIS | 4 | Hold | $92.00 | -4.95% | Maintains | 10 months ago |
Chinook Therapeutics IncKDNY | 1 | Hold | $40.00 | -0.97% | Downgrades | a year ago |
Erasca IncERAS | 2 | Buy | $11.00 | +458.38% | Maintains | a year ago |
Avidity Biosciences IncRNA | 3 | Buy | $20.00 | -32.20% | Upgrades | a year ago |
Bellus Health IncBLU | 3 | Hold | $14.75 | N/A | Downgrades | a year ago |
Atreca IncBCEL | 1 | Hold | $1.50 | N/A | Downgrades | a year ago |
Seagen IncSGEN | 1 | Hold | $229.00 | N/A | Downgrades | a year ago |
Bionomics LimitedBNOX | 2 | Buy | $6.00 | N/A | Upgrades | a year ago |
Neurocrine Biosciences IncNBIX | 2 | Buy | $130.00 | N/A | Upgrades | a year ago |
Denali Therapeutics IncDNLI | 3 | Buy | $50.00 | N/A | Maintains | a year ago |
Tg Therapeutics IncTGTX | 3 | Buy | $25.00 | N/A | Maintains | a year ago |
Myovant Sciences LtdMYOV | 3 | Hold | $27.00 | N/A | Downgrades | 2 years ago |
Regeneron Pharmaceuticals IncREGN | 3 | Hold | $760.00 | N/A | Downgrades | 2 years ago |
Spero Therapeutics IncSPRO | 3 | Buy | $8.00 | N/A | Upgrades | 2 years ago |
Zymeworks IncZYME | 1 | Buy | $15.00 | N/A | Initiates Coverage On | 2 years ago |
Icosavax IncICVX | 1 | Buy | $50.00 | N/A | Initiates Coverage On | 3 years ago |
Tourmaline Bio IncTRML | 1 | Buy | $35.00 | N/A | Initiates Coverage On | 3 years ago |
Viracta Therapeutics IncVIRX | 1 | Buy | $45.00 | N/A | Initiates Coverage On | 3 years ago |
Biomarin Pharmaceutical IncBMRN | 2 | Buy | $100.00 | N/A | Upgrades | 3 years ago |
Cullinan Therapeutics IncCGEM | 1 | Buy | $55.00 | N/A | Initiates Coverage On | 3 years ago |
Beyondspring IncBYSI | 1 | Buy | $30.00 | N/A | Initiates Coverage On | 3 years ago |
Freeline Therapeutics Holdings PLCFRLN | 1 | Buy | $480.00 | N/A | Initiates Coverage On | 4 years ago |
Cymabay Therapeutics IncCBAY | 1 | Buy | $15.00 | N/A | Upgrades | 4 years ago |
Bluebird Bio IncBLUE | 4 | Buy | $100.00 | N/A | Upgrades | 4 years ago |
Regenxbio IncRGNX | 3 | Buy | N/A | N/A | Upgrades | 5 years ago |
Madrigal Pharmaceuticals IncMDGL | 2 | Buy | $250.00 | N/A | Upgrades | 6 years ago |
Shire PLCSHPG | 2 | Hold | N/A | N/A | Downgrades | 6 years ago |
Incyte CorpINCY | 3 | Strong Buy | $85.00 | N/A | Assumes | 6 years ago |
Ionis Pharmaceuticals IncIONS | 2 | Hold | N/A | N/A | Downgrades | 6 years ago |
Voyager Therapeutics IncVYGR | 2 | Hold | N/A | N/A | Downgrades | 6 years ago |
Bioverativ IncBIVV | 3 | Hold | N/A | N/A | Downgrades | 6 years ago |
Uniqure NvQURE | 1 | Buy | $22.00 | N/A | Initiates Coverage On | 7 years ago |
Adamas Pharmaceuticals IncADMS | 1 | Buy | $85.00 | N/A | Initiates Coverage On | 7 years ago |
Audentes Therapeutics IncBOLD1 | 2 | Hold | N/A | N/A | Downgrades | 7 years ago |
Theravance Biopharma IncTBPH | 1 | Buy | N/A | N/A | Initiates Coverage On | 7 years ago |
Spark Therapeutics IncONCE | 1 | Hold | $83.00 | N/A | Initiates Coverage On | 7 years ago |
Avexis IncAVXS | 1 | Buy | $120.00 | N/A | Initiates Coverage On | 7 years ago |
Abbvie IncABBV | 1 | Buy | $95.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.